Q4 2018 Verastem Inc Earnings Call
שיחת ועידה Verastem Inc
Verastem Inc Conference call will be held on 12/03/2019. During the earnings conference call's session Verastem Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Verastem Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are a biopharmaceutical company focused on discovering and developing drugs to improve outcomes for patients with cancer. Our product candidates utilize a multi-faceted approach to treat cancer by reducing cancer stem cells, enhancing anti-tumor immunity, and modulating the local tumor microenvironment. Our most advanced product candidates are VS6063, VS4718, and VS5584. We are currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including lung, ovarian, lymphoma, and pancreatic. We believe that these compounds may be especially beneficial as therapeutics when used in combination with immuno-oncology agents, as well as other current and emerging standard of care treatments in aggressive cancers that have a poorer prognosis and lower overall survival rates when compared to other types of cancer. Our most advanced programs target the Focal Adhesion Kinase (FAK), and the PI3K/mTOR signaling pathways.קרא עוד שיחת ועידה